This site is currently undergoing maintenance.

We apologize for the inconvenience.

Please access the full Prescribing Information, Medication Guide, and Instructions for Use for

  To view PDF documents, you must have Adobe Reader installed on your computer.

Alpha interferons, including INTRON A, cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Patients with persistently severe or worsening signs or symptoms of these conditions should be withdrawn from therapy. In many but not all cases these disorders resolve after stopping INTRON A therapy.

ONCO-1001355-0003 07/14

Copyright © 2014 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
Terms and Conditions | Privacy Policy